REG - Directa Plus PLC - Notice of Interim Results

Directa PlusAnnouncement

08/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230908:nRSH7749La&default-theme=true

RNS Number : 7749L  Directa Plus PLC  08 September 2023

 

8 September 2023

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Notice of Interim Results and Investor Presentations

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets,
confirms it expects to announce its results for the six months ended 30 June
2023 on Wednesday, 27 September 2023. In addition, management will host a live
virtual presentation and Q&A for analysts at 10a.m. on the morning of
publication of the results and a live virtual presentation and Q&A for
retail investors on Friday, 29 September 2023 at 11a.m. on the Investor Meet
Company platform.

 

Both presentations will be given by Giulio Cesareo, Chief Executive Officer,
and Giorgio Bonfanti, Chief Financial Officer.

 

Questions can be submitted at any time during the live presentations.

 

A recording of the presentation will be made available on the Company's
website following the conclusion of the investor presentation.

 

Analyst Presentation

 

To register to attend, please email directaplus@almapr.co.uk

 

Retail Investor Presentation

 

To register to attend, please do so here
(https://www.investormeetcompany.com/directa-plus-plc/register-investor)

 

 Directa Plus plc                                            +39 02 36714458

 Giulio Cesareo, CEO

 Giorgio Bonfanti, CFO

 Cenkos Securities plc (Nominated Adviser and Joint Broker)  +44 131 220 6939

 Neil McDonald

 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)    +44 20 7496 3069

 Rick Thompson

 Phil Davies

 Alma PR (Financial PR Adviser)                              +44 20 3405 0205

 Justine James                                               directaplus@almapr.co.uk

 Hannah Campbell

 Kinvara Verdon

 

Notes to Editors

Directa Plus (www.directa-plus.com (http://www.directa-plus.com) ) is one of
the largest producers and suppliers of graphene-based products for use in
consumer and industrial markets. The Company's graphene manufacturing
capability uses proprietary patented technology based on a plasma super
expansion process. Starting from natural graphite, each step of Directa Plus'
production process - expansion, exfoliation and drying - creates
graphene-based materials and hybrid graphene materials ready for a variety of
uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene
nano-platelets. The products (marketed as G+(R)) have multiple applications
due to its properties. These G+(R) products can be categorised into various
families, with different products being suitable for specific practical
applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORUBRNROKUKRAR